Establishment and validation of a novel risk model for estimating time to first treatment in 120 patients with chronic myelomonocytic leukaemia.
Autoren: Huemer F, Weiss L, Faber V, Neureiter D, Egle A, Geissler K, Voskova D, Zebisch A, Burgstaller S, Pichler A, Stauder R, Sperr W, Lang A, Pfeilstöcker M, Machherndl-Spandl S, Stampfl M, Greil R, Pleyer L.
Journal: Wiener Klinische Wochenschrift / The Middle-European Journal of Medicine
2018
Hematopoietic regeneration after autologous stem cell transplantation with actual body weight based dosing of conditioning chemotherapy